Log In
BCIQ
Print this Print this
 

NK antagonist

  Manage Alerts
Collapse Summary General Information
Company Albireo Pharma Inc.
DescriptionNeurokinin antagonist
Molecular Target Neurokinin 1 substance P (TAC1) (NK1) ; Neurokinin 2 (NK2) receptor (TACR2)
Mechanism of ActionNeurokinin-1 (NK-1) (Substance P) receptor antagonist
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today